Results 201 to 210 of about 178,510 (340)

Dupilumab in Elderly Patients with Atopic Dermatitis-A Systematic Review and Meta-Analysis. [PDF]

open access: yesBiomedicines
Hałubiec P   +4 more
europepmc   +1 more source

The Utility of Intranasal Corticosteroids in Association With Dupilumab for Chronic Rhinosinusitis With Nasal Polyposis: A Real‐Life Multicenter Study by a Tuscany Group

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective Chronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent inflammatory condition often associated with other type‐2 diseases. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has revolutionized the treatment of severe CRSwNP.
Pietro Orlando   +17 more
wiley   +1 more source

Patterns of farm exposure are associated with reduced incidence of atopic dermatitis in early life

open access: green, 2020
Cheryl A. Steiman   +9 more
openalex   +2 more sources

Distinct Nasal Microbiome Profiles and Prediction Model for Allergic Rhinitis, Nonallergic Rhinitis, and Healthy Children

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
The alpha and beta diversity of the nasal microbiome differed among children with allergic rhinitis (AR), nonallergic rhinitis (NAR), and healthy controls (HCs). Compared to HC, AR had more Escherichia‐Shigella, Negativicoccus, and Campylobacter, while NAR had more Dolosigranulum and fewer Enterobacteriaceae.
Kantima Kanchanapoomi   +6 more
wiley   +1 more source

Depression, Anxiety and Quality of Life in Patients with Atopic Dermatitis and Psoriasis. [PDF]

open access: yesMedicina (Kaunas)
Arnīte A   +4 more
europepmc   +1 more source

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki   +24 more
wiley   +1 more source

Does vitamin D deficiency increase severity of atopic dermatitis?

open access: diamond, 2018
Ahmet Şener   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy